It is well known that the addition of spermine or spermidine to culture medium containing ruminant serum inhibits cellular proliferation. This effect is caused by the products of oxidation of polyamines that are generated by serum amine oxidase. Among the products, we found that acrolein is a major toxic compound produced from spermine and spermidine by amine oxidase. We then analysed the level of polyamines (putrescine, spermidine and spermine) and amine oxidase activity in plasma of patients with chronic renal failure. It was found that the levels of putrescine and the amine oxidase activity were increased, whereas spermidine and spermine were decreased in plasma of patients with chronic renal failure. The levels of free and protein-conjugated acrolein were also increased in plasma of patients with chronic renal failure. An increase in putrescine, amine oxidase and acrolein in plasma was observed in all cases such as diabetic nephropathy, chronic glomerulonephritis and nephrosclerosis. These results suggest that acrolein is produced during the early stage of nephritis through kidney damage and also during uraemia through accumulation of polyamines in blood due to the decrease in their excretion into urine.
Introduction
It is well established that polyamines (putrescine, spermidine and spermine) are necessary for cell growth [1, 2] . However, the addition of spermidine or spermine to culture medium containing ruminant serum inhibits cellular proliferation [3, 4] . This effect is caused by the products of oxidation of polyamines that are generated by serum amine oxidase [5] . Ruminant serum amine oxidase catalyses the oxidative deamination of spermidine and spermine to produce, respectively, an aminoaldehyde [N -(4-aminobutyl)-aminopropionaldehyde] or an aminodialdehyde [N,N -bis(3-propionaldehyde)-1,4-butanediamine], with H 2 O 2 and ammonia [6] . Acrolein (CH 2 =CHCHO) is then spontaneously formed from these two aminoaldehydes [7] . Spermine is oxidized as follows: 
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spontaneously [8] .
Polyamines have been suggested to be one of the uraemic toxins [9] . However, this idea has not been carefully explored. In a previous report dealing with uraemia, the total polyamine levels in serum, estimated using an antibody against polyamines, were higher in patients with advanced adult uraemia than in ambulatory uraemic children [9] . In the present study, we determined the levels of each polyamine, i.e. putrescine, spermidine and spermine, together with amine oxidase activity and the level of acrolein in plasma of patients with renal failure. We found that acrolein is a major toxic compound produced from spermine and spermidine by amine oxidase, and that acrolein is accumulated in plasma of patients with chronic renal failure. Furthermore, it was found that the main amine oxidase producing acrolein from spermine and spermidine is polyamine oxidase.
Results and discussion
Correlation between cytotoxicity and acrolein produced from spermine and 3-aminopropanal
As shown in Figure 1 (A), the inhibitory effect of spermine was seen with FM3A cells exposed to spermine in the presence of fetal bovine serum (FBS). The toxicity is caused Figure 1 Effect of spermine (SPM), acrolein and 3-aminopropanal on the growth of FM3A cells cultured in the presence of 2% FBS Cells were cultured under standard conditions [11] except that chemicals and enzymes shown in the figure were added to the medium together with 2% FBS. AG, aminoguanidine; Cat, catalase; ALDH, aldehyde dehydrogenase. Each point is the mean ± S.D. from triplicate determinations.
by factors produced from spermine by amine oxidase. The evidence for this is that aminoguanidine, an inhibitor of amine oxidase, blocked the effects of spermine ( Figure 1A ). Polyamines are converted to aminoaldehydes and H 2 O 2 by amine oxidase [6] . Then acrolein is spontaneously formed from the aminoaldehydes [7] . The concentration of spermine (15-30 µM) that inhibited cell growth was slightly higher than that of acrolein (7.5-15 µM; Figure 1B ), but was much lower than that of H 2 O 2 (0.2-0.4 mM; results not shown).
In addition, aldehyde dehydrogenase, but not catalase, could prevent the effects of spermine on cell growth ( Figure 1C ). These results suggest that acrolein is more strongly involved than H 2 O 2 in the inhibition of cell growth by spermine.
Next we examined the effects of various aldehydes on cell growth to determine whether acrolein is a major inhibitory factor of cell growth. The concentrations of formaldehyde (HCHO), acetaldehyde (CH 3 CHO) and propionaldehyde (CH 3 CH 2 CHO; 0.25-5 mM) required to inhibit cell growth were much higher than that of spermine. However, 3-aminopropanal inhibited cell growth at concentrations (25-50 µM) comparable with that of spermine ( Figure 1D ). The addition of aldehyde dehydrogenase recovered cell growth. Spermidine also inhibited cell growth at concentrations of 0.1-0.15 mM. Acrolein produced from spermine, 3-aminopropanal and spermidine in the presence of FBS was then measured by the method of Alarcon [10] . Table 1 Polyamine contents and amine oxidase activity in plasma of normal subjects and patients with chronic renal failure With written consent, blood was obtained from normal subjects and from patients with chronic renal failure. Blood containing 1 mg/ml disodium EDTA was centrifuged at 1500 g for 30 min at 4 • C. Creatinine in plasma was determined by a standard method for blood chemistry, the creatinaseperoxidase (CRTNase-POD) method. Amino acids in plasma were removed by cellulose phosphate column chromatography before polyamine analysis. To 1.8 ml of plasma, 0.2 ml of 50% trichloroacetic acid was added and centrifuged for 10 min at 12 000 g. The supernatant thus obtained was neutralized with 6 M KOH, and applied to a cellulose phosphate column (1 ml) previously equilibrated with a buffer containing 0.1 M boric acid/Na 2 CO 3 and 0.025 M NaCl (pH 8.0). Amino acids were eluted with 10 ml of the same buffer, and polyamines were then eluted with 3 ml of a buffer containing 0.2 M boric acid/Na 2 CO 3 and 0.8 M NaCl (pH 8.0). Polyamine contents were measured by HPLC as described previously [18] . The reaction mixture for amine oxidase activity (0.075 ml) contained 10 mM Tris/HCl (pH 7.5), 0.2 mM spermine and 0.065 ml of plasma. After incubation at 37 • C for 48 h, 0.55 ml of 5% trichloroacetic acid was added to 0.02 ml of the reaction mixture, which was then centrifuged for 10 min at 12 000 g. A 10 µl aliquot of the supernatant was used for the polyamine measurement by HPLC. Results are means ± S.D.; *P < 0.05, **P < 0.01 and ***P < 0.001 versus normal subjects. Put, putrescine; Spd, spermidine; Spm, spermine. The acrolein produced was in the order spermine > 3-aminopropanal > spermidine, which paralleled the order of cytotoxicity. These results strongly suggest that acrolein, but not aminoaldehyde itself, is a major inhibitory factor of cell growth produced from spermine.
Increase in putrescine, amine oxidase and acrolein in plasma of patients with chronic renal failure
The polyamine content and amine oxidase activity in plasma of patients with renal failure were measured. Plasma was divided into moderate (<8 mg/dl) and severe (>8 mg/dl) classes according to the value of serum creatinine. As shown in Table 1 , the level of putrescine in plasma of patients with renal failure was higher than that in normal subjects, whereas spermidine and spermine levels were lower than those in normal subjects. We next determined the activity of amine oxidase in plasma as the ability of the enzyme to degrade spermine (Table 1) . Amine oxidase activity in plasma of patients with renal failure was higher than that in normal subjects. In general, the change of polyamine levels and the increase in amine oxidase were greater in patients with severe renal failure than in those with moderate failure. The results suggest that acrolein, a toxic compound, is produced from spermidine and spermine by amine oxidase in the plasma of patients with renal failure. Free and protein-conjugated acrolein in plasma were determined by HPLC and ELISA, respectively. As shown in Table 2 , both types of acrolein were increased in plasma of patients with renal failure. The concentration of acrolein that causes 50% inhibition of cell growth (IC 50 ) is 5-10 µM in a cell-culture system [11] . Free acrolein in plasma of uraemic patients was 1-1.4 µM, whereas that in normal subjects was 0.5 µM. The acrolein found as protein conjugates in plasma of uraemic patients was equivalent to 140-170 µM, which is about 5-fold higher than in plasma of normal subjects. The Table 2 Free and protein-conjugated acrolein in plasma of normal subjects and patients with chronic renal failure Acrolein was measured according to the method of Alarcon [10] .
The reaction mixture (0.2 ml) containing 0.1 ml of plasma, 23 mM maminophenol, 43 mM hydroxylamine hydrochloride and 1.5 M HCl was boiled for 10 min. The acrolein was determined by HPLC according to the method of Bohnenstengel et al. [19] using 0.08 ml of supernatant after centrifugation. Fluorescence of 7-hydroxyquinoline (acrolein derivative) was measured at an excitation wavelength of 358 nm and an emission wavelength of 510 nm. Protein-conjugated acrolein [FDP-Lys; N ε -(3-formyl-3,4-dehydropiperidino)-lysine] was determined by the method of Uchida et al. [20] using the ACR-Lysine Adduct ELISA System (NOF Corporation, Tokyo, Japan) and 0.05 ml of plasma. After the reaction was terminated, absorbance at 450 nm was measured by a microplate reader (Bio-Rad model 550). Results are means ± S.D.; **P < 0.01 and ***P < 0.001 versus normal subjects.
Normal subject or patient with
Acrolein content FDP-Lys chronic renal failure (nmol/ml of plasma) (nmol/ml of plasma)
1.02 ± 0.98 138 ± 51.1*** Severe (n = 19)
1.42 ± 0.84** 170 ± 85.8*** results suggest that the levels of free and conjugated acrolein in plasma of patients may be sufficient to cause cell damage. The uraemic patients had diseases with different primary aetiologies. Thus we compared polyamine levels, amine oxidase activity and acrolein levels between patients with different diseases. In all cases (diabetic nephropathy, chronic glomerulonephritis and nephrosclerosis), the changes in polyamine content, amine oxidase activity and proteinconjugated acrolein were very similar (results not shown). The results suggest that production of acrolein is a common feature of patients with chronic renal failure, irrespective of the original disease that leads to renal failure.
We next examined the properties of amine oxidase in plasma of patients with severe renal failure. For this purpose, we studied the effects of an inhibitor of monoamine oxidase, pargyline, an inhibitor of monoamine and diamine oxidases, semicarbazide, and an inhibitor of polyamine oxidase, MDL72527. The activity of amine oxidase in plasma of all eight patients examined was inhibited by MDL72527, and activity in four patients was inhibited by semicarbazide. Pargyline only inhibited activity in plasma of one patient. Inhibition by MDL72527 was greater than that by semicarbazide in plasma of four patients, whose activities were inhibited by semicarbazide. The results indicate that acrolein is produced mainly by polyamine oxidase and partly by diamine oxidase in plasma of these patients.
There are also reports that 3-aminopropanal produced from spermine is strongly involved in cell damage during ischaemia [12, 13] . T-cell proliferation is also repressed by polyamine oxidation in peripheral blood mononuclear cells [14] . In this case, it has been reported that both acrolein and H 2 O 2 produced from spermine are involved in the cell damage. Acrolein has been reported to cause lipid peroxidation of erythrocytes and then haemolysis [15] . Thus acrolein may be involved in various kinds of cell damage. It should be noted that other candidates as uraemic toxins, such as urea, methylguanidine and indoxyl sulphate [16, 17] , did not cause significant cell damage using NIH 3T3 cells in the present study (results not shown).
Our results, taken together, suggest that acrolein is produced from spermine and spermidine during the early stage of nephritis due to kidney damage and also during uraemia through accumulation of polyamines in blood due to the decrease in their excretion into urine.
